Comparison of the Frequency of Bacterial and Viral Infections Among Children with Community-acquired Pneumonia Hospitalized Across Distinct Severity Categories: a Prospective Cross-sectional Study
Overview
Affiliations
Background: The comparison of the frequencies of bacterial and viral infections among children with community-acquired pneumonia (CAP) admitted in distinct severity categories, in an original study, is lacking in literature to-date. We aimed to achieve this goal.
Methods: Children aged 2-59-months-old hospitalized with CAP were included in this prospective study in Salvador, Brazil. Clinical data and biological samples were collected to investigate 11 viruses and 8 bacteria. Severity was assessed by using the World Health Organization criteria.
Results: One hundred eighty-one patients were classified as "non-severe" (n = 53; 29.3 %), "severe" (n = 111; 61.3 %), or "very severe" (n = 17; 9.4 %) CAP. Overall, aetiology was detected among 156 (86.2 %) cases; viral (n = 84; 46.4 %), bacterial (n = 26; 14.4 %) and viral-bacterial (n = 46; 25.4 %) infections were identified. Viral infection frequency was similar in severe/very severe and non-severe cases (46.1 % vs. 47.2 %; p = 0.9). Pneumococcal infection increased across "non-severe" (13.2 %), "severe" (23.4 %), and "very severe" (35.3 %) cases (qui-squared test for trend p = 0.04). Among patients with detected aetiology, after excluding cases with co-infection, the frequency of sole bacterial infection was different (p = 0.04) among the categories; non-severe (12.5 %), severe (29.3 %) or very severe (55.6 %). Among these patients, sole bacterial infection was independently associated with severity (OR = 4.4 [95 % CI:1.1-17.6]; p = 0.04) in a model controlled for age (OR = 0.7 [95 % CI:0.5-1.1]; p = 0.1).
Conclusions: A substantial proportion of cases in distinct severity subgroups had respiratory viral infections, which did not differ between severity categories. Bacterial infection, particularly pneumococcal infection, was more likely among severe/very severe cases.
Leonard S, Guertin H, Odoardi N, Miller M, Patel M, Daley M J Inflamm (Lond). 2024; 21(1):7.
PMID: 38454423 PMC: 10921642. DOI: 10.1186/s12950-024-00379-w.
Cheng J, Ji D, Yin Y, Wang S, Pan Q, Zhang Q Pediatr Res. 2023; 94(1):161-171.
PMID: 36635400 PMC: 9838271. DOI: 10.1038/s41390-022-02431-y.
von Mollendorf C, Berger D, Gwee A, Duke T, Graham S, Russell F J Glob Health. 2022; 12:10009.
PMID: 35866332 PMC: 9305023. DOI: 10.7189/jogh.12.10009.
Rueda Z, Aguilar Y, Maya M, Lopez L, Restrepo A, Garces C BMC Pediatr. 2022; 22(1):169.
PMID: 35361166 PMC: 8968093. DOI: 10.1186/s12887-022-03235-z.
Camacho-Moreno G, Duarte C, Garcia D, Calderon V, Maldonado L, Castellar L Biomedica. 2021; 41(Sp. 2):62-75.
PMID: 34669279 PMC: 8614369. DOI: 10.7705/biomedica.5658.